Rebecca Fischer is an assistant professor in the Department of Epidemiology and Biostatistics at the Texas A&M University School of Public Health. Her research interests are the epidemiology of tropical diseases, epidemic investigations, global health, risk factors for infectious diseases, clinical disease characterization in emerging tropical diseases, infectious disease diagnosis and surveillance in resource-limited settings and utilizing trained students for epidemiological surge capacity needs.
Fischer is the principal investigator for Texas A&M University’s PreventCOVIDU study, which is looking to see if individuals who have received the Moderna COVID-19 can still pass the virus on to others. The study is supported by the U.S. National Institutes of Health and is the first to examine how well vaccines stop infection and block virus transmission.
Fischer was named one of “The Best Things in Texas, 2021” by Texas Monthly for her efforts to provide Texans, and the rest of the world, with accurate guidance on the COVID-19 pandemic.
Fischer received her Bachelor of Science in biology, ecology, evolution and conservation from The University of Texas at Austin, her Master of Public Health in infectious disease epidemiology and her Ph.D. in field epidemiology from The University of Texas Health Science Center School of Public Health. She received her post-doctoral training in tropical medicine from Baylor College of Medicine, and her DTMH in tropical medicine and hygiene from Gorgas Memorial Institute of Tropical and Preventive Medicine.